Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rifaximin (400mg)
Therapeutic Category
Antibacterials, Antibiotic, Antidiarrheal, Gastroenterology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹374/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rifaboly 400 Tablet is a pharmaceutical formulation containing 400 mg of rifaximin, a broad-spectrum antibiotic primarily used to treat gastrointestinal infections. Rifaximin is effective against various strains of bacteria that can cause conditions such as traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy. By targeting the gut, rifaximin helps to restore the natural balance of flora while inhibiting the growth of harmful bacteria.
The mechanism of action involves the inhibition of bacterial RNA synthesis, leading to the elimination of pathogens without significantly affecting the normal gut microbiota. This property makes Rifaboly 400 particularly beneficial for patients seeking targeted treatment with minimal systemic absorption, thereby reducing the risk of widespread antibiotic resistance.
Common side effects may include nausea, headache, and abdominal discomfort; rare but serious effects include severe allergic reactions and liver dysfunction. Patients taking Rifaboly 400 should adhere to the prescribed dosage and duration to maximize therapeutic benefits while minimizing potential adverse effects. It is essential to consult with a healthcare professional if symptoms persist or worsen.
Rifaboly 400 is indicated for the treatment of traveler’s diarrhea caused by non-invasive strains of Escherichia coli, IBS-D, and the reduction of risk of hepatic encephalopathy in patients with liver disease.
Rifaboly 400 is intended for prescription use only; misuse or overuse can lead to antibiotic resistance and should be avoided. Always follow healthcare provider instructions and report any unusual symptoms promptly. This description provides a comprehensive overview of Rifaboly 400, emphasizing its clinical uses and safety profile, making it a valuable option for treating specific gastrointestinal conditions.
Store at room temperature, away from moisture and direct sunlight, keeping out of reach of children.
Composition : Rifaximin (550mg)
Composition : Rifaximin (200mg)
Composition : Amoxycillin (875mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Fluconazole (150mg) + Azithromycin (1gm) + Secnidazole (1gm) Tablet
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus
Composition : Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (125mg)
Composition : Azithromycin (250mg) Tablet
Composition : Azithromycin (500mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rifaximin 400mg Tablet has strong demand in the gastroenterology and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on intestinal infection and gut health portfolios.
Medical distributors and agencies can benefit from consistent demand for gut-specific antibacterial therapy under medical supervision. Rifaximin 400mg is a gut-selective antibiotic with minimal systemic absorption Commonly prescribed for infectious diarrhea, traveler’s diarrhea, IBS-D (irritable bowel syndrome with diarrhea), and small intestinal bacterial overgrowth (SIBO) Helps reduce harmful intestinal bacteria while maintaining better gut tolerability Widely used by gastroenterologists and general physicians Suitable for both acute and chronic gastrointestinal conditions This strengthens a comprehensive gastroenterology and intestinal anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rifaximin 400mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong gastrointestinal prescription demand, repeat usage in chronic gut disorders, specialist gastroenterology sales, and reliable supply chain support, along with attractive margins in the GI segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional pharmaceutical support and a dependable supply chain for sustainable business growth.